Idexx LaboratoriesIDXX is the IBD Stock of the Day for Friday. Shares of the maker of animal diagnostics tools are trading ...

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 fourth quarter and full year financial results for Monday, February 2, 2026 ...

IDEXX Laboratories IDXX has shown remarkable momentum, rallying 64.7% in the last 12 months. The stock has comfortably surpassed the industry’s 2.8% growth and the S&P 500 Composite’s 17.7% gain.

Palo Alto and IDEXX both gained during the Wednesday session, while Capital One Financial and the Materials Select Sector ...

IDEXX Laboratories is expected to release its fiscal fourth-quarter earnings soon, and analysts project a double-digit ...

Ratings for IDEXX Laboratories (NASDAQ:IDXX) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table provides a quick overview ...

While they might not represent the most exciting field in the biotech space, animal healthcare companies have been a steady, consistent source of growth in what's often a turbulent market. One company ...

According to Benzinga Pro, IDEXX Laboratories Inc's peer group average for short interest as a percentage of float is 5.39%, which means the company has less short interest than most of its peers.

IDEXX Laboratories, Inc. is a U.S. healthcare company, that currently leads the veterinary industry developing diagnostics tools to satisfy veterinarians’ everyday needs. IDEXX has delivered solid and ...

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced third quarter results. Third Quarter Results The Company ...